Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

154.43
-0.0800-0.05%
Post-market: 154.21-0.2200-0.14%19:52 EDT
Volume:8.75M
Turnover:1.35B
Market Cap:10.16B
PE:8.47
High:156.74
Open:156.41
Low:153.58
Close:154.51
52wk High:169.89
52wk Low:102.55
Shares:65.80M
Float Shares:65.80M
Volume Ratio:1.04
T/O Rate:13.30%
Dividend:0.55
Dividend Rate:0.35%
EPS(TTM):18.23
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Health Care up on Drug Breakthrough Hopes - Health Care Roundup

Dow Jones
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Sector Update: Healthcare

MT Newswires Live
·
Sep 22

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Sep 22

Valneva (VALN) Gets a Buy from H.C. Wainwright

TIPRANKS
·
Sep 22

H.C. Wainwright Remains a Buy on Purple Biotech (PPBT)

TIPRANKS
·
Sep 22

Oncolytics Biotech (ONCY) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 22

Krystal Biotech is Maintained at Buy by B of a Securities

Dow Jones
·
Sep 22

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live
·
Sep 22

William Blair biotech analyst holds an analyst/industry conference call

TIPRANKS
·
Sep 22

Health Care Roundup: Market Talk

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: NewAmsterdam Pharma Company (NAMS) and Lipocine (LPCN)

TIPRANKS
·
Sep 22

Space Biomedicine Accelerates Toward Commercialization: CAS Space and Guangzhou Laboratory Join Forces for Orbital Drug Development

Deep News
·
Sep 21

LEPU ScienTech Delays Circular on Major Shanghai Biotech Acquisition

TIPRANKS
·
Sep 21

Wedbush biotech analyst holds an analyst/industry conference call

TIPRANKS
·
Sep 21

Dr. Agarwal’s Health Care clears all resolutions at virtual 16th AGM

TIPRANKS
·
Sep 21

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL) and AgomAb Therapeutics NV ADR (AGMB)

TIPRANKS
·
Sep 21

Health Insurance Quality Upgrade: One Year On, Product Innovation and Regulatory Correction Advance Side by Side, With Payment-Side Momentum Building

Deep News
·
Sep 21

Sector Update: Healthcare

MT Newswires Live
·
Sep 21

BofA Adjusts Price Target on Krystal Biotech to $400 From $392, Keeps Buy Rating

MT Newswires Live
·
Sep 21